236 related articles for article (PubMed ID: 26184313)
1. Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins.
Schaefer SM; Gottschalk CH; Jabbari B
Toxins (Basel); 2015 Jul; 7(7):2615-28. PubMed ID: 26184313
[TBL] [Abstract][Full Text] [Related]
2. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
Mitchell MP; Schaecher K; Cannon HE; Speckman M
J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
4. [Potential antinociceptive mechanisms of botulinum toxin].
Aoki KR; Francis J; Jost WH
Schmerz; 2006 Sep; 20(5):381-2, 384-7. PubMed ID: 16819667
[TBL] [Abstract][Full Text] [Related]
5. Chronic migraine: current concepts and ongoing treatments.
Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
[TBL] [Abstract][Full Text] [Related]
6. Use of botulinum toxins for chronic headaches: a focused review.
Loder E; Biondi D
Clin J Pain; 2002; 18(6 Suppl):S169-76. PubMed ID: 12569965
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial].
Artemenko AR; Abramov VG; Bozhenkina TV; Konovalova ZN; Korenko AN; Krasavina DA; Kurenkov AL; Latysheva NV; Naprienko MV; Orlova OR; Filatova EG; Shevchenko VS; Iakovleva PN
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):64-74. PubMed ID: 37994890
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for the treatment of chronic migraine: the placebo effect.
Solomon S
Headache; 2011 Jun; 51(6):980-4. PubMed ID: 21631480
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxins in the treatment of migraine and tension-type headaches.
Winner P
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):885-99. PubMed ID: 14580043
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin therapy of migraine and tension-type headache: comparing different botulinum toxin preparations.
Schulte-Mattler WJ; Martinez-Castrillo JC
Eur J Neurol; 2006 Feb; 13 Suppl 1():51-4. PubMed ID: 16417598
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
Giri S; Tronvik E; Linde M; Pedersen SA; Hagen K
Cephalalgia; 2023 Apr; 43(4):3331024231156922. PubMed ID: 36856015
[TBL] [Abstract][Full Text] [Related]
13. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
Freitag FG; Diamond S; Diamond M; Urban G
Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
[TBL] [Abstract][Full Text] [Related]
14. Use of botulinum toxin type B for migraine and tension headaches.
Fadeyi MO; Adams QM
Am J Health Syst Pharm; 2002 Oct; 59(19):1860-2. PubMed ID: 12374073
[No Abstract] [Full Text] [Related]
15. Migraines in Women: Current Evidence for Management of Episodic and Chronic Migraines.
Deneris A; Rosati Allen P; Hart Hayes E; Latendresse G
J Midwifery Womens Health; 2017 May; 62(3):270-285. PubMed ID: 28561915
[TBL] [Abstract][Full Text] [Related]
16. Emerging treatment for chronic migraine and refractory chronic migraine.
Lionetto L; Negro A; Palmisani S; Gentile G; Del Fiore MR; Mercieri M; Simmaco M; Smith T; Al-Kaisy A; Arcioni R; Martelletti P
Expert Opin Emerg Drugs; 2012 Sep; 17(3):393-406. PubMed ID: 22862686
[TBL] [Abstract][Full Text] [Related]
17. Headache and botulinum toxin.
Porta M; Camerlingo M
J Headache Pain; 2005 Sep; 6(4):325-7. PubMed ID: 16362701
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin and the treatment of headache: A clinical review.
Finkel AG
Toxicon; 2015 Dec; 107(Pt A):114-9. PubMed ID: 26365919
[TBL] [Abstract][Full Text] [Related]
19. Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine.
Andreou AP; Leese C; Greco R; Demartini C; Corrie E; Simsek D; Zanaboni A; Koroleva K; Lloyd JO; Lambru G; Doran C; Gafurov O; Seward E; Giniatullin R; Tassorelli C; Davletov B
Neurotherapeutics; 2021 Jan; 18(1):556-568. PubMed ID: 33205382
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A for the treatment of migraine.
Aurora S
Expert Opin Pharmacother; 2006 Jun; 7(8):1085-95. PubMed ID: 16722818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
